Coagulation parameters (PT, APTT, INR) as determinants of peri-lesional attenuation and clinical severity in intracerebral hemorrhage: A retrospective analytical study

Ardy Ariady  Saruman; Muhammad Yunus Amran; Muhammad  Akbar; Andi Alfian  Zainuddin; Andi Weri  Sompa; Citra  Rosyidah

doi:10.23750/abm.2026.18823

Authors

Ardy Ariady Saruman Department of Neurology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Muhammad Yunus Amran Division of Interventional Neurology and Neuroendovascular Therapy, Department of Neurology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia; Brain Centre, Dr. Wahidin Sudirohusodo General Hospital, Makassar, Indonesia; Hasanuddin University Teaching Hospital, Makassar, Indonesia https://orcid.org/0000-0001-5079-7490
Muhammad Akbar Department of Neurology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia; Hasanuddin University Teaching Hospital, Makassar, Indonesia
Andi Alfian Zainuddin Department of Public Health and Community Medicine, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Andi Weri Sompa Department of Neurology, Faculty of Medicine and Health Sciences, Universitas Muhammadiyah, Makassar, Indonesia https://orcid.org/0000-0002-2154-9225
Citra Rosyidah Department of Physiology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia

Keywords:

intracerebral hemorrhage , coagulation parameters, hounsfield unit, peri-lesional attenuation, NIHSS, chest CT scan

Abstract

Background and aim: Intracerebral hemorrhage (ICH) is associated with high mortality and severe neurological disability, largely driven by secondary brain injury such as perihematomal edema (PHE) and hematoma expansion. Abnormalities in coagulation parameters, including prothrombin time (PT), activated partial thromboplastin time (APTT), and international normalized ratio (INR), may be associated with bleeding characteristics and radiological features. Quantitative assessment of peri-lesional attenuation using Hounsfield Unit (HU) values on non-contrast computed tomography (NCCT) provides a practical approach to evaluate tissue changes. This study aimed to investigate the relationship between coagulation parameters, peri-lesional attenuation, and neurological severity measured by the National Institutes of Health Stroke Scale (NIHSS) in patients with ICH.

Methods: This study used an analytic observational design with a retrospective approach in patients with primary ICH treated at Dr. Wahidin Sudirohusodo Hospital, Makassar. Data were obtained from medical records, including PT, APTT, and INR values, NCCT findings for HU measurement using a region-of-interest (ROI) method, and NIHSS scores at admission. Statistical analysis was performed to assess relationships between variables, with a significance level of p < 0.05.

Results: A total of 150 patients were included, with a predominance of male patients and a mean age of 55.1 ± 15.2 years. A weak but statistically significant association was observed between INR and peri-lesional attenuation. However, coagulation parameters were not significantly associated with neurological severity as measured by NIHSS. Multivariate analysis showed that age and hematoma volume were the main independent predictors of neurological severity.

Conclusions: Coagulation parameters show a limited association with peri-lesional attenuation and are not significantly associated with clinical severity in patients with ICH. Clinical and radiological factors, particularly age and hematoma volume, remain the primary determinants of early neurological impairment. Integration of laboratory and imaging findings may support clinical evaluation, although their predictive value for early severity appears limited.

References

1. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632-44. doi: 10.1016/S0140-6736(09)60371-8.

2. Magid-Bernstein J, Girard R, Polster S, et al. Cerebral hemorrhage: pathophysiology, treatment, and future directions. Circ Res. 2022;130(8):1204-29. doi: 10.1161/CIRCRESAHA.121.319949.

3. GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0.

4. Campbell BCV, Khatri P. Stroke. Lancet. 2020;396(10244):129-42. doi: 10.1016/S0140-6736(20)31179-X.

5. Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439-48. doi: 10.1161/CIRCRESAHA.116.308413.

6. Chen S, Yang Q, Chen G, Zhang JH. An update on inflammation in the acute phase of intracerebral hemorrhage. Transl Stroke Res. 2015;6(1):4-8. doi: 10.1007/s12975-014-0384-4.

7. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720-31. doi: 10.1016/S1474-4422(12)70104-7.

8. Chen Y, Chen S, Chang J, Wei J, Feng M, Wang R. Perihematomal edema after intracerebral hemorrhage: an update on pathogenesis, risk factors, and therapeutic advances. Front Immunol. 2021;12:740632. doi: 10.3389/fimmu.2021.740632.

9. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5(1):53-63. doi: 10.1016/S1474-4422(05)70283-0.

10. Huan R, Li Y, Tan J, Tang J, Huang N, Cheng Y. The Hounsfield unit of perihematomal edema is associated with poor clinical outcomes in intracerebral hemorrhage. World Neurosurg. 2021;146:e829-36. doi: 10.1016/j.wneu.2020.11.025.

11. Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol. 2008;7(3):256-67. doi: 10.1016/S1474-4422(08)70041-3.

12. Hillal A, Ullberg T, Ramgren B, Wassélius J. Computed tomography in acute intracerebral hemorrhage: neuroimaging predictors of hematoma expansion and outcome. Insights Imaging. 2022;13(1):180. doi: 10.1186/s13244-022-01309-1.

13. Jeong HG, Bang JS, Kim BJ, Bae HJ, Han MK. Hematoma Hounsfield units and expansion of intracerebral hemorrhage: a potential marker of hemostatic clot contraction. Int J Stroke. 2021;16(2):163-71. doi: 10.1177/1747493019895703.

14. Morotti A, Goldstein JN. Diagnosis and management of acute intracerebral hemorrhage. Emerg Med Clin North Am. 2016;34(4):883-99. doi: 10.1016/j.emc.2016.06.010.

15. Boulouis G, Morotti A, Charidimou A, Dowlatshahi D, Goldstein JN. Noncontrast computed tomography markers of intracerebral hemorrhage expansion. Stroke. 2017;48(4):1120-5. doi: 10.1161/STROKEAHA.116.015062.

16. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359(9):938-49. doi: 10.1056/NEJMra0801082.

17. Dorgalaleh A, Favaloro EJ, Bahraini M, Rad F. Standardization of prothrombin time/international normalized ratio (PT/INR). Int J Lab Hematol. 2021;43(1):21-28. doi: 10.1111/ijlh.13349.

18. Steiner T, Bösel J. Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke. 2010;41(2):402-9. doi: 10.1161/STROKEAHA.109.552919.

19. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438-40. doi: 10.1016/S2352-3026(20)30145-9.

20. Kuramatsu JB, Gerner ST, Schellinger PD, et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 2015;313(8):824-36. doi: 10.1001/jama.2015.0846.

21. Ziai WC, Carhuapoma JR. Intracerebral hemorrhage. Continuum (Minneap Minn). 2018;24(6):1603-22. doi: 10.1212/CON.0000000000000672.

22. McGurgan IJ, Ziai WC, Werring DJ, Al-Shahi Salman R, Parry-Jones AR. Acute intracerebral haemorrhage: diagnosis and management. Pract Neurol. 2020;21(2):128-36. doi: 10.1136/practneurol-2020-002763.

23. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032-60. doi: 10.1161/STR.0000000000000069.

24. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke. 2007;38(3):1072-5. doi: 10.1161/01.STR.0000258078.35316.30.

25. Wan Y, Holste KG, Hua Y, Keep RF, Xi G. Brain edema formation and therapy after intracerebral hemorrhage. Neurobiol Dis. 2023;176:105948. doi: 10.1016/j.nbd.2022.105948.

26. Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66(8):1175-81. doi: 10.1212/01.wnl.0000208408.98482.99.